116 related articles for article (PubMed ID: 9005146)
1. Colorectal cancer--a multivariate analysis of prognostic factors.
Wolters U; Stützer H; Keller HW; Schröder U; Pichlmaier H
Eur J Surg Oncol; 1996 Dec; 22(6):592-7. PubMed ID: 9005146
[TBL] [Abstract][Full Text] [Related]
2. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
3. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
5. Blood transfusion and prognosis in Dukes' B and C colorectal cancer.
Bentzen SM; Balslev I; Pedersen M; Teglbjaerg PS; Hanberg-Sørensen F; Bone J; Jacobsen NO; Sell A; Overgaard J; Bertelsen K
Eur J Cancer; 1990 Apr; 26(4):457-63. PubMed ID: 2141511
[TBL] [Abstract][Full Text] [Related]
6. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial.
Riethmüller G; Holz E; Schlimok G; Schmiegel W; Raab R; Höffken K; Gruber R; Funke I; Pichlmaier H; Hirche H; Buggisch P; Witte J; Pichlmayr R
J Clin Oncol; 1998 May; 16(5):1788-94. PubMed ID: 9586892
[TBL] [Abstract][Full Text] [Related]
8. Perioperative blood transfusions reduce long-term survival following surgery for colorectal cancer.
Edna TH; Bjerkeset T
Dis Colon Rectum; 1998 Apr; 41(4):451-9. PubMed ID: 9559629
[TBL] [Abstract][Full Text] [Related]
9. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined.
Cianchi F; Palomba A; Boddi V; Messerini L; Pucciani F; Perigli G; Bechi P; Cortesini C
World J Surg; 2002 Mar; 26(3):384-9. PubMed ID: 11865379
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma.
Diez M; Cerdán FJ; Pollán M; Maestro ML; Ortega MD; Martínez S; Moreno G; Balibrea JL
Anticancer Res; 1994; 14(6B):2819-25. PubMed ID: 7872725
[TBL] [Abstract][Full Text] [Related]
11. Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients.
Mulder WM; Stern PL; Stukart MJ; de Windt E; Butzelaar RM; Meijer S; Adér HJ; Claessen AM; Vermorken JB; Meijer CJ; Wagstaff J; Scheper RJ; Bloemena E
Clin Cancer Res; 1997 Nov; 3(11):1923-30. PubMed ID: 9815581
[TBL] [Abstract][Full Text] [Related]
12. Factors predictive of survival in patients with node-positive colorectal cancer in Taiwan.
Wang WS; Chen PM; Chiou TJ; Liu JH; Fan FS; Lin TC; Jiang JK; Yang SH; Yen CC; Wang HS; Lin JK
Hepatogastroenterology; 2000; 47(36):1590-4. PubMed ID: 11149009
[TBL] [Abstract][Full Text] [Related]
13. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group.
Riethmüller G; Schneider-Gädicke E; Schlimok G; Schmiegel W; Raab R; Höffken K; Gruber R; Pichlmaier H; Hirche H; Pichlmayr R
Lancet; 1994 May; 343(8907):1177-83. PubMed ID: 7909866
[TBL] [Abstract][Full Text] [Related]
14. Correlation between postoperative infections and long-term survival after colorectal resection for cancer.
Nespoli A; Gianotti L; Totis M; Bovo G; Nespoli L; Chiodini P; Brivio F
Tumori; 2004; 90(5):485-90. PubMed ID: 15656334
[TBL] [Abstract][Full Text] [Related]
15. Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer.
Louhimo J; Carpelan-Holmström M; Alfthan H; Stenman UH; Järvinen HJ; Haglund C
Int J Cancer; 2002 Oct; 101(6):545-8. PubMed ID: 12237895
[TBL] [Abstract][Full Text] [Related]
16. Prognosis in Duke's B colorectal carcinoma: the Jass classification revisited.
De Quay N; Cerottini JP; Albe X; Saraga E; Givel JC; Caplin S
Eur J Surg; 1999 Jun; 165(6):588-92. PubMed ID: 10433145
[TBL] [Abstract][Full Text] [Related]
17. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
[TBL] [Abstract][Full Text] [Related]
18. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
[TBL] [Abstract][Full Text] [Related]
19. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma.
Purdie CA; Piris J
Histopathology; 2000 Feb; 36(2):121-6. PubMed ID: 10672056
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in colorectal cancer.
Cerottini JP; Caplin S; Pampallona S; Givel JC
Oncol Rep; 1999; 6(2):409-14. PubMed ID: 10023012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
